FDA To Discuss Child COVID-19 Vaccine In June; Moderna, Pfizer Request Emergency Use Authorization

The U.S. Food and Drug Administration (FDA) has announced tentative June dates for the meeting of its advisory committee to discuss authorizing COVID-19 vaccines for young children below the age of five years.
FDA has set aside June 8, 21, and 22 for virtual meetings of its Vaccines and Related Biological Products Advisory Committee. The agency will discuss updates on Moderna’s and Pfizer’s requests for Emergency Use Authorization (EUA) for their COVID-19 vaccines targeting “younger populations,” FDA said in an April 29 news release.
At present, children aged 5 years and older can be vaccinated in the United States, leaving 18 million children below the age of five who are not approved for a COVID-19 vaccine.
…  » Read full article